港股異動丨中國石油AH股齊漲 三季度大賺400.5億元 前三季度實現扭虧
格隆匯10月30日丨中國石油股份(00857.HK)漲2.29%;中國石油(601857.SH)則漲1.48%。中石油昨日盤後公佈,第三季度純利同比大增353.6%至400.5億元,較前兩季明顯改善。若剔除管道資產重組收益,核心利潤亦達218.03億元,不過,受累於上半年的嚴重虧損,中石油前三季純利仍然大幅倒退73%,僅100.67億元。中石油指,首三季原油平均實現價格為每桶40.06美元,按年跌34.9%,其中國內實現價格41.43美元,下降32.5%。天然氣方面,天然氣平均實現價格為每千立方英尺4.61美元,下降16%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.